JOHNSON INVESTMENT COUNSEL INC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$406,329
-2.8%
3,352
-8.2%
0.01%0.0%
Q2 2023$418,227
-16.5%
3,652
+0.5%
0.01%
-28.6%
Q1 2023$500,736
+6.4%
3,6330.0%0.01%
+16.7%
Q4 2022$470,764
-11.8%
3,633
-24.8%
0.01%
-25.0%
Q3 2022$534,000
-50.3%
4,833
-66.3%
0.01%
-46.7%
Q2 2022$1,074,000
-15.6%
14,333
-12.0%
0.02%
-6.2%
Q1 2022$1,272,000
+396.9%
16,281
+985.4%
0.02%
+300.0%
Q4 2020$256,0001,5000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders